HIV-1 load comparison using four commercial real-time assays

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 292-297

  Bourlet, Thomas ^a   Signori Schmuck, Anne ^b   Roche, Laurent ^c,d   Icard, Vinca ^c,e   Saoudin, Henia ^a   Trabaud, Mary Anne ^c,e   Tardy, Jean Claude ^c,e   Morand, Patrice ^b   Pozzetto, Bruno ^a   Ecochard, René ^c   André, Patrice ^c,e  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HÔPITAL MICHALLON   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANALYZER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SEROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650881529     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01688-10     Document Type: Article

References (23)

1. Altman, D. G., and J. M. Bland. 1983. Measurement in medicine: the analysis of method comparison studies. Statistician 32:307-317.
2. Damond, F., B. Roquebert, A. Benard, G. Collin, M. Miceli, P. Yeni, F. Brun-Vezinet, and D. Descamps. 2007. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 45:3436-3438.
3. De Bel, A., D. Marissens, L. Debaisieux, C. Liesnard, S. Van den Winjngaert, S. Lauwers, and D. Piérard. 2010. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan Assay. J. Clin. Microbiol. 48:1337-1342.
4. de Mendoza, C., M. Koppelman, B. Montes, V. Ferre, V. Soriano, H. Cuypers, M. Segondy, and T. Oosterlaken. 2005. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J. Virol. Methods 127:54-57.
5. Fiscus, S. A., B. Cheng, S. M. Crowe, L. Demeter, C. Jennings, V. Miller, R. Respess, and W. Stevens. 2006. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3:e417.
6. Frange, P., J. Galimand, N. Vidal, C. Goujard, C. Deveau, F. Souala, M. Peeters, L. Meyer, C. Rouzioux, and M. L. Chaix. 2008. New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study. Retrovirology 5:69.
7. Garcia-Diaz, A., G. S. Clewly, C. L. Booth, W. Labett, N. McAllister, and A. M. Geretti. 2006. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J. Clin. Microbiol. 44:1788-1791.
8. Gueudin, M., J. C. Plantier, V. Lemee, M. P. Schmitt, L. Chartier, T. Bourlet, A. Ruffaut, F. Damond, M. Vray, and F. Simon. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505.
9. Holguin, A., M. Lopez, M. Molinero, and V. Soriano. 2008. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA, v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol. 46:2918-2923.
10. Labbett, W., A. Garcia-Diaz, Z. Fox, G. S. Clewlay, T. Fernandez, M. Johnson, and A. M. Geretti. 2009. Comparative evaluation of the ExaVirTM load version 3 reverse transcriptase assay for the measurement of HIV-1 plasma viral load. J. Clin. Microbiol. 47:3266-3270.
11. Lima, V., R. Harrigton, and J. S. G. Montaner. 2009. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J. Acquir. Immune Defic. Syndr. 51:3-6.
12. MacDougall, D. S. 1996. Quantitative measurement of HIV RNA: techniques and clinical applications. J. Int. Assoc. Physicians AIDS Care 2:9-14.
13. Pas, S., J. W. A. Rossen, D. Schoener, D. Thamke, A. Pettersson, R. Babiel, and M. Schutten. 2010. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 48:1195-1200.
14. Peter, J. B., and R. A. Blum. 2002. Monitoring HIV viral loads in the United States: recent trends and methodologies. J. Acquir. Immune Defic. Syndr. 30:261-262.
15. Rouet, F., V. Foulongne, J. Viljoen, K. Steegen, P. Becquart, D. Valea, S. Danaviah, M. Segondy, C. Verhofstede, and P. Van de Perre, for the WHO/ ANRS 1289 Kesho Bora Study Group. 2010. Comparison of the generic HIV Viral Load®, Amplicor™ HIV-1 Monitor v1.5 and Nuclisens HIV-1 EasyQ® v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study. J. Virol. Methods 163:253-257.
16. Schumacher, W., E. Frick, M. Kauselmann, V. Maier-Hoyle, R. Van der Vliet, and R. Babiel. 2007. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J. Clin. Virol. 38:304-312.
17. Scott, L., S. Carmona, and W. Stevens. 2009. The performance of the new Roche COBAS Ampli/COBAS TaqMan HIV-1 version 2.0 assay. J. Clin. Microbiol. 47:3400-3402.
18. Scott, L. E., L. D. Noble, J. Moloi, L. Erasmus, W. D. F. Venter, and W. Stevens. 2009b. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J. Clin. Microbiol. 47:2209-2217.
19. Reference deleted.
20. Swanson, P., C. de Mendoza, Y. Joshi, A. Golden, R. L. Hodinka, V. Soriano, S. G. Devare, and J. Hackett, Jr. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868.
21. UNAIDS. 2008. Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ .
22. van Zyl, G. U., S. N. J. Korsman, L. Maree, and W. Preiser. 2010. NucliSens EasyQ® HIV-1 V1.2 system: detection of human plasma-derived background signal. J. Virol. Methods 165:318-319.
23. Wittek, M., M. Sturmer, H. W. Doerr, and A. Berger. 2007. Molecular assays for monitoring HIV infection and antiretroviral therapy. Expert Rev. Mol. Diagn. 7:237-246.